Baron Capital, an investment management company, released its Q3 2026 investor letter for the “Baron Health Care Fund”. During the quarter ended September 30, 2026, Baron Health Care Fund® advanced 4.02%, underperforming the Russell 3000 Health Care Index’s 6.19% gain. Since its inception, the Fund’s annualized growth is 10.80%, slightly above the Benchmark. Disappointing stock selection, particularly in biotechnology, contributed to the Fund trailing the Benchmark by 217 basis points....
Baron Health Care Fund’s Q3 2026 Investor Letter
